U.S. Authorities Quiz Astrazeneca Over Brilinta Clinical Trial

The U.S. Department of Justice has opened an investigation into a clinical trial testing AstraZeneca’s Brilinta. While the cause of the investigation is being kept quiet, the drugmaker says it is cooperating with authorities.
Reuters